Table 2 The clinical characteristics of extended samples by prostate biopsy for qPCR included in our study
From: Characterization and validation of long noncoding RNAs as new candidates in prostate cancer
NO | Gender | Age (years) | Histological type | Initial total PSA | Gleason score | Proportion of Cancer tissue |
|---|---|---|---|---|---|---|
001 | Man | 62 | Adenocarcinoma | 10.44 | 3 + 4 | 80% |
002 | Man | 51 | Adenocarcinoma | 8.08 | 4 + 5 | 70% |
003 | Man | 53 | Adenocarcinoma | 9.11 | 4 + 4 | 30% |
004 | Man | 54 | Adenocarcinoma | 8.48 | 3 + 3 | 5% |
005 | Man | 55 | Adenocarcinoma | 11.84 | 4 + 3 | 60% |
006 | Man | 63 | Normal tissue | 10.92 | / | / |
007 | Man | 78 | Normal tissue | 9.46 | / | / |
008 | Man | 50 | Normal tissue | 9.56 | / | / |
009 | Man | 63 | Normal tissue | 12.71 | / | / |
010 | Man | 72 | Normal tissue | 10.82 | / | / |
011 | Man | 77 | Normal tissue | 8.33 | / | / |
012 | Man | 58 | Normal tissue | 9.21 | / | / |